Skip to search.
 TSX Up 0.40% TSX Ventures Down 0.19%

Delcath Systems, Inc. (DCTH)

-NasdaqCM
1.42 Up 0.57(66.94%) May 27, 4:00PM EDT
Add to Portfolio
Prev Close:0.85
Open:0.90
Bid:1.46 x 3500
Ask:1.51 x 3400
1y Target Est:1.30
Beta:1.71
Earnings Date:Aug 4 - Aug 10 (Est.)
Day's Range:0.89 - 1.77
52wk Range:0.80 - 3.00
Volume:10,486,211
Avg Vol (3m):259,441
Market Cap:17.28M
P/E (ttm):N/A
EPS (ttm):-1.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DCTHUp 66.94%17.28M
LLYUp 0.79%79.32B
ONXX 0.00%N/A
PFEUp 0.56%211.21B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:4.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback